Market Access Transformation Launches Envision, a New Payer Research Platform that Forecasts the Market Access Viability of Recently Approved Products
Envision is the only syndicated research platform that provides forward thinking evaluations of the market access viability for a product after it has received positive EMA or FDA guidance. Market
Source: finanznachrichten.de